Login

Not yet a member?Join now!|Lost password

  • About us
  • Coverage
  • Services
  • Contact us

Introducing noodls' taxonomychannels content

In this page, you can see the noodls coverage for the Pharmaceuticals channel in detail.

On the left, you have the local and international coverage, including figures about active sources, average daily noodls and total available PR contacts.

Below the coverage statistics, you have a list of the most active sources in the channel.

On the right, you have the total active sources for the selected channel divided by the groups to which they belong.

You can browse sub-channels, if any, by clicking on the icons on the bottom of the page.

Related links

  • Channels main page

Pharmaceuticals

Local coverage

  • Active sources: 353
  • Average daily noodls: 238
  • PR contacts: 897

International coverage

  • Active sources: 880
  • Average daily noodls: 296
  • PR contacts: 2,188

Most active sources

  • Repros Therapeutics Inc.
  • Bayer AG
  • Bayer HealthCare AG
  • GSK - GlaxoSmithKline plc
  • ProStrakan Group plc
  • Helicon Group Limited
  • PT Kalbe Farma Tbk
  • Norwegian Association of Pharmaceutical Manufacturers
  • Zeltia SA
  • Agenix Limited

Related sources by group

  • 665 Pharmaceutical Companies
  • 90 Research and Development Activities
  • 68 Holdings
  • 32 Professional, Business and Trade Associations
  • 32 Animal Pharmaceutical Companies
  • 25 Wholesale Trade Companies
  • 12 Drug Retailers
  • 7 Policy and Regulation Authorities
  • 6 Government Agencies
  • 4 Market Research and Polling Companies
  • 3 Scientific Institutes
  • 3 Mail Order Houses
  • 2 Online Service, Web Portal and Search Engine Companies
  • 2 International Institutions
  • 1 Trade Shows
  • 1 Manufacturers of Medical, Precision and Optical Instruments

Our coverage

Stats

  • Today's noodls379

  • Average daily noodls10,945

  • Archived noodls5,763,904

  • Active sources29,423

  • PR contacts77,755

More

copyright ©2006-2010 noodls.com | Privacy Policy | Terms of Use | Feedback